The Cancer Center's Computational Sciences (CS) group leverages the power of interdisciplinary thinking by partnering theorists, experimentalists and software engineers in a cooperative atmosphere accessible to experimentalists. Through CS, Cancer Center members apply advanced computational techniques to discover the hidden order in complex data sets and to decipher the languages of biology. CS is dedicated to the development and implementation of algorithms, and the application of visualization tools, relational databases and high-performance computing facilities to the understanding of complex biological processes. The operation comprises six functional service delivery areas;Applications Development (APRS), Statistics &Analysis (SA), High Performance Computing (HPC), Colony Management Systems (CMS) and Cancer Bioinformatics Grid (caBIG) which are all supported by the Software Quality Assurance (SQA) group. All CS functional groups access the same support tools including a dedicated Work Management System and associated process standards, including Software Configuration Management and Software Development Life Cycle practices. Through CS, Cancer Center members access discovery tools and compute systems they would otherwise struggle to employ. The Integrated Services Information System, supporting process and data management functions across the Scientific Services, was developed and is maintained by CS. A diverse consortium of biologists, statisticians, mathematicians, computer scientists and database specialists are essential to this effort. CS, which occupies 1,044 ft2 of interactive space in Research Laboratory Unit 4 and Building 46, employs six software engineers, one software configuration management engineer, one high-performance computing specialist, and a caBIG liaison all managed by a Senior Software Engineer as well as three biostatistician/bioinformaticists and analysts reporting to a bioinformaticist manager. Co-Project Leaders Drs. Carol Bult and Gary Churchill oversee this operation which has grown from its inception in 1999 from one full time employee (FTE) to a department of 14 FTEs in 2005. Drs. Bult and Churchill communicate with the Cancer Center users and Service staff to ensure that research needs are met in the most efficient, cost-effective and technically current manner.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Center Core Grants (P30)
Project #
Application #
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Jackson Laboratory
Bar Harbor
United States
Zip Code
Jung, Seung-Hyun; Kim, Min Sung; Lee, Sung-Hak et al. (2016) Whole-exome sequencing identifies recurrent AKT1 mutations in sclerosing hemangioma of lung. Proc Natl Acad Sci U S A 113:10672-7
Qin, Wenning; Kutny, Peter M; Maser, Richard S et al. (2016) Generating Mouse Models Using CRISPR-Cas9-Mediated Genome Editing. Curr Protoc Mouse Biol 6:39-66
Tai, Derek J C; Ragavendran, Ashok; Manavalan, Poornima et al. (2016) Engineering microdeletions and microduplications by targeting segmental duplications with CRISPR. Nat Neurosci 19:517-22
Sundberg, John P; Pratt, C Herbert; Silva, Kathleen A et al. (2016) Dermal lymphatic dilation in a mouse model of alopecia areata. Exp Mol Pathol 100:332-6
Parvanov, Emil D; Tian, Hui; Billings, Timothy et al. (2016) PRDM9 interactions with other proteins provide a link between recombination hotspots and the chromosomal axis in meiosis. Mol Biol Cell :
Ali, Riyasat; Babad, Jeffrey; Follenzi, Antonia et al. (2016) Genetically modified human CD4(+) T cells can be evaluated in vivo without lethal graft-versus-host disease. Immunology 148:339-51
Ishimura, Ryuta; Nagy, Gabor; Dotu, Ivan et al. (2016) Activation of GCN2 kinase by ribosome stalling links translation elongation with translation initiation. Elife 5:
Jangalwe, Sonal; Shultz, Leonard D; Mathew, Anuja et al. (2016) Improved B cell development in humanized NOD-scid IL2Rγ(null) mice transgenically expressing human stem cell factor, granulocyte-macrophage colony-stimulating factor and interleukin-3. Immun Inflamm Dis 4:427-440
Samanta, S; Sun, H; Goel, H L et al. (2016) IMP3 promotes stem-like properties in triple-negative breast cancer by regulating SLUG. Oncogene 35:1111-21
Korstanje, Ron; Deutsch, Konstantin; Bolanos-Palmieri, Patricia et al. (2016) Loss of Kynurenine 3-Mono-oxygenase Causes Proteinuria. J Am Soc Nephrol 27:3271-3277

Showing the most recent 10 out of 958 publications